Psoriasis, biologic therapy, and the pandemic of the 21st century

Detalhes bibliográficos
Autor(a) principal: Nogueira, Miguel
Data de Publicação: 2020
Outros Autores: Vender, Ron, Torres, Tiago
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/2586
Resumo: The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient.
id RCAP_c05a6332ec1dfdda0a8bf0e6e8bbaf62
oai_identifier_str oai:repositorio.chporto.pt:10400.16/2586
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Psoriasis, biologic therapy, and the pandemic of the 21st centuryCOVID-19SARS-CoV-2biologiccoronavirus; psoriasisThe pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient.Bioexcel PublishingRepositório Científico do Centro Hospitalar Universitário de Santo AntónioNogueira, MiguelVender, RonTorres, Tiago2021-11-22T11:57:12Z2020-05-142020-05-14T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/2586engNogueira M, Vender R, Torres T. Psoriasis, biologic therapy, and the pandemic of the 21st century. Drugs Context. 2020;9:2020-4-10. doi:10.7573/dic.2020-4-101745-198110.7573/dic.2020-4-10info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T11:01:11Zoai:repositorio.chporto.pt:10400.16/2586Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:38:47.115066Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Psoriasis, biologic therapy, and the pandemic of the 21st century
title Psoriasis, biologic therapy, and the pandemic of the 21st century
spellingShingle Psoriasis, biologic therapy, and the pandemic of the 21st century
Nogueira, Miguel
COVID-19
SARS-CoV-2
biologic
coronavirus; psoriasis
title_short Psoriasis, biologic therapy, and the pandemic of the 21st century
title_full Psoriasis, biologic therapy, and the pandemic of the 21st century
title_fullStr Psoriasis, biologic therapy, and the pandemic of the 21st century
title_full_unstemmed Psoriasis, biologic therapy, and the pandemic of the 21st century
title_sort Psoriasis, biologic therapy, and the pandemic of the 21st century
author Nogueira, Miguel
author_facet Nogueira, Miguel
Vender, Ron
Torres, Tiago
author_role author
author2 Vender, Ron
Torres, Tiago
author2_role author
author
dc.contributor.none.fl_str_mv Repositório Científico do Centro Hospitalar Universitário de Santo António
dc.contributor.author.fl_str_mv Nogueira, Miguel
Vender, Ron
Torres, Tiago
dc.subject.por.fl_str_mv COVID-19
SARS-CoV-2
biologic
coronavirus; psoriasis
topic COVID-19
SARS-CoV-2
biologic
coronavirus; psoriasis
description The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood. The impact of COVID-19 on patients with psoriasis under biologic agents is continuously being observed in this rapidly changing pandemic. A case-by-case evaluation must be made by dermatologists, and the final decision should be discussed and decided by both the patient and the specialist. Observations reveal that immunosuppressive therapy may have a role in the treatment of this virus, placing emphasis on the scenario of safety through maintenance of therapy with biologic agents, especially when there are no signs or symptoms related to the infection or contact with an infected patient.
publishDate 2020
dc.date.none.fl_str_mv 2020-05-14
2020-05-14T00:00:00Z
2021-11-22T11:57:12Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/2586
url http://hdl.handle.net/10400.16/2586
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Nogueira M, Vender R, Torres T. Psoriasis, biologic therapy, and the pandemic of the 21st century. Drugs Context. 2020;9:2020-4-10. doi:10.7573/dic.2020-4-10
1745-1981
10.7573/dic.2020-4-10
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Bioexcel Publishing
publisher.none.fl_str_mv Bioexcel Publishing
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133648415358976

Registros relacionados